To better understand the role and functional significance of URAT1 inhibition in the pathophysiology of metabolic heart disease, we investigated whether URAT1 is expressed in the heart and—if so—URAT1-selective inhibition directly ameliorates myocardial injury associated with metabolic syndrome. The gene discussed is SLC22A12; the disease is metabolic syndrome.